ArticleInternational journal of women's health2026
Burden, Trends, and Future Projections of Polycystic Ovary Syndrome in the Gulf Cooperation Council Countries, 1990-2023, with Projections to 2050: A Global Burden of Disease Study.
Article in International journal of women's health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Polycystic ovary syndrome (PCOS) is a common endocrine disorder in women of reproductive age, with reproductive, metabolic, and long-term health consequences. Data on PCOS burden in the Gulf Cooperation Council (GCC) remain limited and inconsistent. This study evaluated temporal trends, determinants, and future projections of PCOS across the GCC. Methods: We estimated PCOS prevalence, incidence, and disability-adjusted life-years in the six GCC countries from 1990 to 2023 using Global Burden of Disease (GBD) 2023 data. Trends were assessed using annual percentage change and joinpoint regression, and case-number changes were decomposed into population growth, ageing, and epidemiological change. Associations with the Socio-demographic Index and socioeconomic inequality were assessed, alongside ecological correlations with metabolic risk indicators, and future trends to 2050 were projected using ARIMA/ETS models validated by backtesting. Results: The age-standardized prevalence of PCOS in 2023 ranged from 2377 per 100,000 women in Oman to 2679 in Kuwait, exceeding regional and global benchmarks; affected women rose from 173,203 in 1990 to 621,812 in 2023. All GCC countries showed increasing trends, with burden highest among women aged 20-24 years. Population growth accounted for 71% of the case-number rise, rising age-specific rates for 26%, and age structure for 3%. Prevalence and DALY rates were positively associated with SDI ( Conclusion: PCOS is an emerging, increasingly shared public health problem across the GCC, with a burden exceeding international benchmarks, driven predominantly by population growth and associated with rising obesity; forecasting models suggest continued increases in the coming decades. Increased surveillance, standardized early diagnosis, and integrated reproductive-metabolic health strategies are needed across the region.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.